Its pipeline includes treatments for bipolar depression, agitation in Alzheimer’s disease, schizophrenia and Parkinson’s ...

"Just three years after filing an Investigational New Drug application for CYB003 ... our belief that CYB003 could have the ...

UB neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication ...

Repetitive transcranial magnetic stimulation offers rapid depression relief for patients unresponsive to conventional treatments. Accelerated over just five days, this therapy targets key brain areas ...

Emerging research suggests that chronic inflammation, rather than neurotransmitter deficiencies alone, may be a major factor ...

David Walt, the Hansjörg Wyss Professor of Bioinspired Engineering at HMS and professor of pathology at Brigham and Women’s Hospital, is operating at a microscopic level, observing cell abnormalities ...

Bright light therapy, a standard treatment for seasonal depression, may also help people who experience depression year-round, a study shows. Researchers found that patients with non-seasonal ...

“FDA cleared transcranial magnetic stimulation is a proven and effective treatment with minimal side effects. We designed the Inspire to enable both experienced TMS providers as well as those who are ...

Therapy provided via telehealth can reduce a person's risk of suicide, a new study reports. Cognitive behavior therapy ...

Postpartum depression, a mental health condition affecting millions of new mothers, may soon be easier to diagnose and treat, ...

Uterine fibroids are a common condition that affects up to 80% of women in their lifetime. Nearly half of those women will experience symptoms that affect their quality of life and fertility, ...